Target Entity: Sarvottam Health Care Private Limited (Kakinada)

Type of Deal: Acquisition of majority stake (51%)

Stake/Capacity: 51% equity stake (21,72,713 equity shares of Rs. 10 each) in a 183-bed hospital facility

Deal Value: Up to ₹80.00 Crore (Rupees Eighty Crore only)

Funding Source: Cash consideration

Financial Impact:

The target entity reported the following financials:

  • FY 2025-26 Turnover: ₹84.83 Crore
  • FY 2025-26 PAT: ₹70.55 Crore
  • FY 2025-26 Networth: ₹50.30 Crore

Historical turnover:

  • FY26: ₹84.83 Crore
  • FY25: ₹81.38 Crore
  • FY24: ₹74.36 Crore

Timeline: Expected completion on or before 31.10.2026

Strategic Rationale:

KIMS, being the Operations & Management (O & M) Partner of the target entity, has decided to acquire up to 51% of the total equity stake as a strategic investment. The acquisition represents a strategic investment that strengthens KIMS's operational control and ownership in the facility.

Approval Status: Board-approved on 06th October, 2026

Reference Regulation: SEBI Regulation 30 of Listing Obligations and Disclosure Requirements Regulations, 2015, read with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026

Additional Target Entity Details:

  • Date of Incorporation: 19-04-2011
  • Location: Kakinada, Andhra Pradesh, India
  • Commenced operations in 2010 with initial capacity of 50 beds under brand name "Trust Multi Speciality Hospital"
  • Present capacity: 183 beds
  • Facility includes a state-of-the-art hospital building comprising cellar + ground floor with 7 upper floors (G+7 structure)
  • Total built-up area: approximately 9847.23 square meters
  • Land: company-owned land measuring 3001.36 Sq Yards
  • One of the largest and most comprehensive healthcare providers in Kakinada

Transaction Details:

  • Valuation conducted by BDO Valuation Advisory LLP dated 05th October, 2026
  • Does not fall within the definition of Related Party Transaction
  • No promoter/promoter group/group companies have any interest in the entity being acquired
  • No governmental or regulatory approvals required